Coya Therapeutics (NASDAQ:COYA) Given Buy Rating at Chardan Capital
Coya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at Chardan Capital in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $14.00 price target on the stock. Chardan Capital’s price objective indicates a potential upside of 146.05% from the company’s previous […]
Coya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at Chardan Capital in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $14.00 price target on the stock. Chardan Capital’s price objective indicates a potential upside of 146.05% from the company’s previous […]
